NCT01830738

Brief Summary

The main objective of the study is the comparison of the effective duration of hospitalization following laparoscopic hysterectomy via a single-port peri-umbilical technique versus an conventional multi-port technique.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2014

Geographic Reach
1 country

3 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 12, 2013

Completed
10 months until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

October 22, 2015

Status Verified

October 1, 2015

Enrollment Period

6 months

First QC Date

April 10, 2013

Last Update Submit

October 21, 2015

Conditions

Keywords

laparoscopyhysterectomysingle-port trocarsurgical techniquetrocar

Outcome Measures

Primary Outcomes (1)

  • Length of hospital stay in hours

    Maximum 1 month (usually 3 to 5 days)

Secondary Outcomes (21)

  • Difference in hours between real discharge time and theoretical discharge time

    4 weeks

  • Bleeding/fluid loss: Difference between lavage fluids and aspiration fluids

    Day 0 (during surgery)

  • Change in hemoglobin measure

    Day 3 versus baseline

  • Change in hematocrit measure

    Day 3 versus baseline

  • Surgical time, from first incision to closing

    Day 0 (during surgery)

  • +16 more secondary outcomes

Study Arms (2)

Peri-umbilical single-port

EXPERIMENTAL

Patients in this arm have a hysterectomy via a single-port peri-umbilical laparoscopic surgical technique. Intervention: Single-port, peri-umbilical hysterectomy

Procedure: Single-port, peri-umbilical hysterectomy

Multi-port

ACTIVE COMPARATOR

Patients in this arm have a hysterectomy via a conventional multi-port laparoscopic surgical technique. Intervention: Multi-port hysterectomy

Procedure: Multi-port hysterectomy

Interventions

Patients in this arm have a hysterectomy via a single-port peri-umbilical laparoscopic surgical technique.

Peri-umbilical single-port

Patients in this arm have a hysterectomy via a conventional multi-port laparoscopic surgical technique.

Multi-port

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient must have given her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 12 months of follow-up
  • The patient is declared fit by the anesthetist for an intervention by laparoscopy

You may not qualify if:

  • The patient is not available for 12 months of follow-up
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient is not insured or beneficiary of a health insurance plan
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient cannot read French
  • Patient with a history of pelvic radiotherapy
  • Patient with a history of pelvic surgery or serious risk of major adhesions
  • The patient is pregnant
  • Contraindications for anesthesia for either surgical technique
  • Promontofixation or lymphadenectomy
  • No associated procedure other than morcellation or vaginal suture for extracting the hysterectomy specimen, unilateral or bilateral oophorectomy
  • The patient has a known or suspected allergy to polyurethane
  • Extended hysterectomy for neoplastic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

APHM - Hôpital de la Conception

Marseille, 13385, France

Location

CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France

Location

CHU de Saint Etienne - Hôpital Nord

Saint-Priest-en-Jarez, 42270, France

Location

Study Officials

  • Vincent Letouzey, MD

    Centre Hospitalier Universitaire de Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 10, 2013

First Posted

April 12, 2013

Study Start

February 1, 2014

Primary Completion

August 1, 2014

Study Completion

April 1, 2015

Last Updated

October 22, 2015

Record last verified: 2015-10

Locations